Corcept Therapeutics, Inc. (CORT)

NoDoughBro (70.80) Submitted: 10/21/2009 11:39:43 PM : Start Price: $2.33 CORT Score: -16.20

Gimme drugs...gimme drugs.

tiobueno (96.86) Submitted: 4/4/2008 12:29:13 PM : Start Price: $3.56 CORT Score: -25.59

March 27, 2008 12:44 PM EDT

Corcept Therapeutics Inc. (Nasdaq: CORT) Director, Joseph Cook, bought 176,522 on 3/25 at $2.77, bringing his stake to 1,656,360 shares. In addition, Director, David Mahoney, bought 70,609 shares on 3/25 at $2.77, bringing his stake to 636,547 shares.

Corcept Therapeutics Incorporated develops drugs for the treatment of severe psychiatric and metabolic diseases. [LJ]

Ajiday (< 20) Submitted: 4/4/2008 7:30:22 AM : Start Price: $3.80 CORT Score: -30.16

Health, health, health! One cannot go wrong with health. And the more they specialize and branch out, the better the prospects for these companies.

elwood713 (< 20) Submitted: 4/2/2008 3:59:18 PM : Start Price: $3.79 CORT Score: -29.59

Since the inception of this stock, given it's highs and lows, the trend shows the stock outperforming the S&P 500.

godsmacks1 (98.08) Submitted: 12/19/2007 1:43:29 PM : Start Price: $2.84 CORT Score: +7.09

sub prime

microstockguru (< 20) Submitted: 9/25/2007 11:40:00 AM : Start Price: $4.62 CORT Score: -32.06

Corcept Therapeutics has jumped from around $2 to $4.50 on a notification from the FDA.